160 related articles for article (PubMed ID: 35711913)
1. A Ubiquitin-Proteasome Gene Signature for Predicting Prognosis in Patients With Lung Adenocarcinoma.
Tang Y; Guo Y
Front Genet; 2022; 13():893511. PubMed ID: 35711913
[No Abstract] [Full Text] [Related]
2. Development and validation of a robust immune-related prognostic signature in early-stage lung adenocarcinoma.
Wu P; Zheng Y; Wang Y; Wang Y; Liang N
J Transl Med; 2020 Oct; 18(1):380. PubMed ID: 33028329
[TBL] [Abstract][Full Text] [Related]
3. Establishment and validation of a prognostic signature for lung adenocarcinoma based on metabolism-related genes.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Cancer Cell Int; 2021 Apr; 21(1):219. PubMed ID: 33858449
[TBL] [Abstract][Full Text] [Related]
4. A nomogram for predicting prognosis of multiple myeloma patients based on a ubiquitin-proteasome gene signature.
Ji D; Liu Y; Sun W; Shi Q; Chen G; Song Z; Jiang Y
Aging (Albany NY); 2022 Dec; 14(24):9951-9968. PubMed ID: 36534449
[TBL] [Abstract][Full Text] [Related]
5. A Seven-Gene Signature with Close Immune Correlation Was Identified for Survival Prediction of Lung Adenocarcinoma.
Zou X; Hu Z; Huang C; Chang J
Med Sci Monit; 2020 Jul; 26():e924269. PubMed ID: 32613949
[TBL] [Abstract][Full Text] [Related]
6. A four-gene prognostic signature for predicting the overall survival of patients with lung adenocarcinoma.
Liu L; He H; Peng Y; Yang Z; Gao S
PeerJ; 2021; 9():e11911. PubMed ID: 34631307
[TBL] [Abstract][Full Text] [Related]
7. Development and validation of a nomogram with an epigenetic signature for predicting survival in patients with lung adenocarcinoma.
Wang J; He L; Tang Y; Li D; Yang Y; Zeng Z
Aging (Albany NY); 2020 Nov; 12(22):23200-23216. PubMed ID: 33221751
[TBL] [Abstract][Full Text] [Related]
8. An
Han Y; Wong FC; Wang D; Kahlert C
Cancer Inform; 2022; 21():11769351221100727. PubMed ID: 35645555
[TBL] [Abstract][Full Text] [Related]
9. A seven-gene prognostic signature predicts overall survival of patients with lung adenocarcinoma (LUAD).
Al-Dherasi A; Huang QT; Liao Y; Al-Mosaib S; Hua R; Wang Y; Yu Y; Zhang Y; Zhang X; Huang C; Mousa H; Ge D; Sufiyan S; Bai W; Liu R; Shao Y; Li Y; Zhang J; Shi L; Lv D; Li Z; Liu Q
Cancer Cell Int; 2021 Jun; 21(1):294. PubMed ID: 34092242
[TBL] [Abstract][Full Text] [Related]
10. Development of a novel embryonic germline gene-related prognostic model of lung adenocarcinoma.
Liu L; Xu K; Zhou Y
PeerJ; 2021; 9():e12257. PubMed ID: 34721973
[TBL] [Abstract][Full Text] [Related]
11. An Aging-Related Gene Signature-Based Model for Risk Stratification and Prognosis Prediction in Lung Adenocarcinoma.
Xu Q; Chen Y
Front Cell Dev Biol; 2021; 9():685379. PubMed ID: 34277626
[TBL] [Abstract][Full Text] [Related]
12. DNA methylation profiling to predict recurrence risk in stage Ι lung adenocarcinoma: Development and validation of a nomogram to clinical management.
Ma X; Cheng J; Zhao P; Li L; Tao K; Chen H
J Cell Mol Med; 2020 Jul; 24(13):7576-7589. PubMed ID: 32530136
[TBL] [Abstract][Full Text] [Related]
13. Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma.
Cao Y; Lu X; Li Y; Fu J; Li H; Li X; Chang Z; Liu S
PeerJ; 2020; 8():e10320. PubMed ID: 33344071
[TBL] [Abstract][Full Text] [Related]
14. Comprehensive Analysis of Immune Implication and Prognostic Value of
Zeng Y; Zhang Z; Chen H; Fan J; Yuan W; Li J; Zhou S; Liu W
Front Oncol; 2021; 11():798425. PubMed ID: 35047409
[TBL] [Abstract][Full Text] [Related]
15. Identification of a novel autophagy signature for predicting survival in patients with lung adenocarcinoma.
Duan J; Lei Y; Lv G; Liu Y; Zhao W; Yang Q; Su X; Song Z; Lu L; Shi Y
PeerJ; 2021; 9():e11074. PubMed ID: 33976960
[TBL] [Abstract][Full Text] [Related]
16. A signature of tumor DNA repair genes associated with the prognosis of surgically-resected lung adenocarcinoma.
Yang X; Wang G; Gu R; Xu X; Zhu G
PeerJ; 2020; 8():e10418. PubMed ID: 33304656
[TBL] [Abstract][Full Text] [Related]
17. Identification of a methylomics-associated nomogram for predicting overall survival of stage I-II lung adenocarcinoma.
Wang H; Wei C; Pan P; Yuan F; Cheng J
Sci Rep; 2021 May; 11(1):9938. PubMed ID: 33976305
[TBL] [Abstract][Full Text] [Related]
18. Development and validation of a novel epigenetic-related prognostic signature and candidate drugs for patients with lung adenocarcinoma.
Wang Z; Embaye KS; Yang Q; Qin L; Zhang C; Liu L; Zhan X; Zhang F; Wang X; Qin S
Aging (Albany NY); 2021 Jul; 13(14):18701-18717. PubMed ID: 34285141
[TBL] [Abstract][Full Text] [Related]
19. Construction and validation of a novel prognostic signature of microRNAs in lung adenocarcinoma.
Li W; Liu S; Su S; Chen Y; Sun G
PeerJ; 2021; 9():e10470. PubMed ID: 33510968
[TBL] [Abstract][Full Text] [Related]
20. Identification of a Ubiquitin Related Genes Signature for Predicting Prognosis of Prostate Cancer.
Song G; Zhang Y; Li H; Liu Z; Song W; Li R; Wei C; Wang T; Liu J; Liu X
Front Genet; 2021; 12():778503. PubMed ID: 35111198
[No Abstract] [Full Text] [Related]
[Next] [New Search]